How a French Couple Funded IVF in Israel as Non-Residents

Result: A completed IVF course delivered on Israel's private track with a fixed written price agreement and a signed, translated embryo-disposition framework, all arranged from France · Timeline: About 7 weeks from first consultation to embryo transfer · Challenge: Funding and lawfully consenting to fertility treatment in Israel as non-residents outside the public health basket · Authority: Ministry of Health (Misrad HaBriut) · Financial Impact: A per-cycle cost of about NIS 22,000 plus roughly NIS 8,000 in medication, fixed in advance rather than open-ended

Background

A couple from Lyon in their early forties had spent three years in the French fertility system without a pregnancy. The wife was approaching the age ceiling that French public reimbursement applies to assisted reproduction, and the clinic waiting times at home kept pushing their next cycle further out. A relative in Israel had been treated successfully at a Tel Aviv hospital known for its fertility unit, and they decided they wanted to try there. Neither of them was Israeli. Neither had any status in the country beyond a tourist entry, and neither spoke Hebrew.

They assumed, as many do, that a major Israeli hospital would simply take them as patients the way it takes anyone who walks in. What they had not accounted for was that Israel's generous public fertility coverage is built for residents, and that as visitors from France they would stand entirely outside it. Every shekel of the treatment would be theirs to pay, and every consent form they signed would sit under Israeli medical law, not French.

The Challenge

Two things made this more than booking an appointment.

The first was money, and specifically the gap between two national systems. Israel funds IVF unusually generously for its residents, but that basket is defined by residency, and a French couple on a tourist entry are private payers from the first consultation. On the French side, national health insurance reimburses assisted reproduction carried out in France, and treatment outside the European Union is not reimbursed without a prior authorisation that is not given for a country like Israel. So the couple faced the worst of both, no Israeli public funding and no French reimbursement, and they needed to know the real, total cost before committing rather than discovering it invoice by invoice.

The second was consent and control of the embryos. Israeli fertility treatment is tightly regulated, and the rules about who must consent, what happens to frozen embryos if the couple separates, and how long material may be stored are matters of Israeli law and hospital protocol. A couple treated abroad needs those terms spelled out and translated, because a dispute about embryos created in Tel Aviv would be decided in Israel under Israeli regulation regardless of the couple living in France. Signing a stack of Hebrew consent forms they could not read, without understanding the disposition terms, was a risk in itself.

In Practice: Under the National Health Insurance Law 1994, the funded fertility basket is available only to a resident (toshav), so a non-resident pays privately, about NIS 22,000 for a single IVF cycle on a public hospital's private track plus roughly NIS 8,000 in hormonal medication, payable in advance to the hospital's finance office. Fertility units operate under the Public Health Regulations (In Vitro Fertilization) 1987 and are licensed and supervised by the Ministry of Health (Misrad HaBriut), while informed consent is governed by Section 13 of the Patient Rights Law 1996. A full cycle from initial consultation to embryo transfer runs about six to eight weeks, and the written consent covering storage and disposition of embryos must be signed by both partners before retrieval.

What We Did

We handled the arrangement as a cross-border matter, part medical logistics and part legal protection, so the couple travelled only when treatment actually required their presence.

We opened the file with the hospital's private patient and medical tourism office and secured a written treatment plan with a fixed price schedule, so the couple knew the per-cycle cost, the medication cost, and the storage fees before anyone booked a flight. We arranged certified translations of the core consent documents so both partners understood, in French, exactly what they were signing, particularly the clauses on how long embryos would be stored and what would happen to them on separation, incapacity, or death. Where the standard forms left a term unclear, we had it clarified in writing rather than assumed.

We coordinated the timing around the wife's cycle, which is the part that catches foreign patients out. Much of the early monitoring could be done in France and sent ahead, but retrieval and transfer had to happen in Israel within a narrow window, so we lined up the schedule with the unit and built the travel around it. On the financial side we confirmed the reality of French reimbursement in advance, so the couple did not budget for a refund that was never coming, and we noted the treatment for their French tax position, where medical expenses can carry their own relief.

The Outcome

The couple completed a full cycle on the hospital's private track, with retrieval and transfer done during a single stay in Israel and the surrounding monitoring handled from home. The cost landed where the written plan said it would, about NIS 22,000 for the cycle and close to NIS 8,000 in medication, with no surprise charges bolted on at the end, because the price had been fixed before treatment began.

Just as valuable to them was the certainty around consent. They left Israel with a signed, translated framework governing their stored embryos, so the terms that would apply to any future cycle or any disagreement were settled in advance and understood in their own language. They knew that French national insurance would not reimburse the treatment, they had planned for that, and they understood how the expense sat against their French tax return. The wider picture of paying privately for Israeli care as a visitor, and what a hospital will ask for upfront, is set out in our guide to fertility treatment in Israel for non-residents.

Key Takeaways

What this case illustrates for non-residents in similar situations:

1. Israel's fertility funding is for residents. Under the National Health Insurance Law 1994 a visitor is a private payer from the first appointment, so budget for the full cost rather than expecting any public subsidy.
2. Do not count on reimbursement back home. French national insurance does not cover assisted reproduction performed outside the European Union without a prior authorisation that Israel does not qualify for, so the treatment is effectively self-funded.
3. Fix the price in writing first. A written treatment plan covering the cycle, medication, and storage lets you commit knowing the total, instead of learning it invoice by invoice from abroad.
4. Understand the consent you sign. Embryos created in Israel are governed by Israeli regulation and hospital protocol, so get the storage and disposition terms translated and clarified before retrieval, not after a dispute.
5. Plan the trip around the biology. Early monitoring can often be done at home, but retrieval and transfer must happen in Israel in a short window, so the travel has to be built around the cycle.

---

Facing a Similar Situation?

If you are considering fertility treatment in Israel from abroad, the cost, the cross-border reimbursement question, and the consent framework for your embryos are all best settled in writing before you begin.

Contact us for a confidential consultation about your Israeli legal matter.